b-Arrestins in the Immune System - Progress in Molecular Biology and Translational Science - page 381

128. Chen W, Kirkbride KC, How T, et al. Beta-arrestin 2 mediates endocytosis of type III
TGF-beta receptor and down-regulation of its signaling. Science . 2003;301:1394 - 1397.
129. Lee NY, Kirkbride KC, Sheu RD, Blobe GC. The transforming growth factor-beta
type III receptor mediates distinct subcellular trafficking and downstream signaling
of activin-like kinase (ALK)3 and ALK6 receptors. MolBiolCe . 2009;20:
4362- 4370.
130. Mythreye K, Blobe GC. The type III TGF-beta receptor regulates epithelial and cancer
cell migration through beta-arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci
USA . 2009;106:8221- 8226.
131. Lovgren AK, Kovacs JJ, Xie T, et al. beta-Arrestin deficiency protects against pulmo-
nary fibrosis in mice and prevents fibroblast invasion of extracellular matrix. Sci Transl
Med . 2011;3:74ra23.
132. Milasta S, Evans NA, Ormiston L, Wilson S, Lefkowitz RJ, Milligan G. The sustain-
ability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a
single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK
MAPK regulation. Biochem J . 2005;387:573- 584.
133. Tasken K, Stokka AJ. The molecular machinery for cAMP-dependent immuno-
modulation in T-cells. Biochem Soc Trans . 2006;34:476- 479.
134. Bitto A, Minutoli L, David A, et al. Flavocoxid, a dual inhibitor of COX-2 and 5-LOX
of natural origin, attenuates the inflammatory response and protects mice from sepsis.
Crit Care . 2012;16:R32.
135. Fan H, Bitto A, Zingarelli B, et al. Beta-arrestin 2 negatively regulates sepsis-induced
inflammation. Immunology . 2010;130:344- 351.
136. Coureuil M, Mikaty G, Miller F, et al. Meningococcal type IV pili recruit the polarity
complex to cross the brain endothelium. Science . 2009;325:83- 87.
137. Tourret J, Finlay BB. A receptor for meningococcus: eliciting beta-arrestin signaling for
barrier breaching. Dev Cell . 2011;20:7- 8.
138. Lecuyer H, Nassif X, Coureuil M. Two strikingly different signaling pathways are
induced by meningococcal type IV pili on endothelial and epithelial cells. Infect Immun .
2012;80:175- 186.
139. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science .
2005;308:512- 517.
140. Papp M, Li X, Zhuang J, Wang R, Uhal BD. Angiotensin receptor subtype AT(1)
mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell
Mol Physiol . 2002;282:L713- L718.
141. Uhal BD, Li X, Xue A, Gao X, Abdul-Hafez A. Regulation of alveolar epithelial cell
survival by the ACE-2/angiotensin 1-7/Mas axis. Am J Physiol Lung Cell Mol Physiol .
2011;301:L269 - L274.
142. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-mediated gene trans-
fer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat
lung. J Clin Invest . 1997;100:768- 776.
143. Lee CG, Cho SJ, Kang MJ, et al. Early growth response gene 1-mediated apoptosis is
essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med .
2004;200:377- 389.
144. Munger JS, Huang X, Kawakatsu H, et al. The integrin alpha v beta 6 binds and acti-
vates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibro-
sis. Cell . 1999;96:319- 328.
145. Tager AM, Kradin RL, LaCamera P, et al. Inhibition of pulmonary fibrosis by the che-
mokine IP-10/CXCL10. Am J Respir Cell Mol Biol . 2004;31:395 - 404.
146. Jiang D, Liang J, Campanella GS, et al. Inhibition of pulmonary fibrosis in mice by
CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest .

2010;120:2049- 2057.